Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: Evidence from the MIST2 randomised controlled trial.

The MIST2 trial showed that combined intrapleural use of tissue plasminogen activator (t-PA) and DNase was effective when compared to single agents or placebo. However, the treatment costs are significant and overall cost-effectiveness of combined therapy remains unclear.An economic evaluation of th...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Luengo-Fernandez, R, Penz, E, Dobson, M, Psallidas, I, Nunn, A, Maskell, N, Rahman, N
Formáid: Journal article
Teanga:English
Foilsithe / Cruthaithe: European Respiratory Society Publications 2019